Onivyde Injection, Powder, For Solution
Product Images NDC 15054-0043

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Onivyde (NDC 15054-0043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipsen Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Onivyde 01)

Chemical Structure (Onivyde 01)
Chemical structure of irinotecan hydrochloride trihydrate, the active ingredient in Onivyde injection powder for solution.*
FDA Label Image

Chemical Structure (Onivyde 02)

Chemical Structure (Onivyde 02)
A Kaplan-Meier survival curve comparing the probability of survival over time (months) for two treatment groups: ONIVYDE/5-FU/LV (blue line) and 5-FU/LV (red dashed line). The x-axis represents time from randomization in months, and the y-axis represents the probability of survival from 0 to 1. A table below the graph shows the number of patients at risk at various time points for both groups.*
FDA Label Image

Principal Display Panel (43 mg/10 mL Vial Label)

Principal Display Panel (43 mg/10 mL Vial Label)
Onivyde 43 mg/10 mL (4.3 mg/mL) injection powder for solution label. The product is an intravenous liposomal formulation of irinotecan hydrochloride, for single-dose infusion. Label advises refrigeration at 2°C to 8°C, storage in original carton to protect from light, and notes it is a cytotoxic agent. Manufactured by Ipsen Biopharmaceuticals, Inc.*
FDA Label Image

Principal Display Panel (43 mg/10 mL Vial Carton)

Principal Display Panel (43 mg/10 mL Vial Carton)
Packaging label for Onivyde (irinotecan liposome injection) 43 mg/10 mL (4.3 mg/mL) injection, powder for solution, for intravenous infusion after dilution. The label indicates it is a cytotoxic agent, single dose vial with instructions to discard unused portions. Labeler is Ipsen Biopharmaceuticals, Inc. Green and white color scheme with barcode and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.